MEDIORG logo

Medicamen Organics Limited Stock Price

NSEI:MEDIORG Community·₹315.3m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

MEDIORG Share Price Performance

₹0
-60.55 (-100.00%)
₹0
-60.55 (-100.00%)
Price ₹0

MEDIORG Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Solid track record with excellent balance sheet.

3 Risks
2 Rewards

Medicamen Organics Limited Key Details

₹394.3m

Revenue

₹244.7m

Cost of Revenue

₹149.6m

Gross Profit

₹103.8m

Other Expenses

₹45.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
3.91
37.93%
11.60%
47.5%
View Full Analysis

About MEDIORG

Founded
1995
Employees
114
CEO
Bal Gupta
WebsiteView website
www.medicamenorganics.com

Medicamen Organics Limited develops, manufactures, and distributes a range of pharmaceutical dosage. The company offers anti-bacterial, anti-diarrheal, anti-fungal, anti-malarial, anti-diabetic, dental cure, proton pump inhibitor, anti-protozoal, anti-histamine, anti-hypertensive, anti-lipidemic, anti-parasitic, multivitamin, multimineral, and non-steroidal anti-inflammatory drugs in the form of tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. It also provides skincare, haircare, and cosmetic products under the LOIRE brand. The company markets its products to government and private institutions as contract manufacturer/third party manufacturer; and private pharmaceutical companies through third party distributors or on loan license basis across India; African, CIS, and Southeast Asian Countries; and internationally. Medicamen Organics Limited was formerly known as Panchdeep Pharmaceuticals Limited and changed its name to Medicamen Organics Limited in November 1995. The company was incorporated in 1995 and is based in New Delhi, India.

Recent MEDIORG News & Updates

It's A Story Of Risk Vs Reward With Medicamen Organics Limited (NSE:MEDIORG)

Nov 04
It's A Story Of Risk Vs Reward With Medicamen Organics Limited (NSE:MEDIORG)

Recent updates

No updates